Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
Amylin Pharmaceuticals, Inc.and Eli Lilly and Company in a conference call provided context and additional information regarding the August 18, 2008 U.S. Food and Drug Administration (FDA) update to a prior alert for BYETTA(R) injection referencing p... Read more...IDM Pharma reports second quater financial results
IDM Pharma, Inc.reported financial results for the quarter ended June 30, 2008. Financial ...
Meta-Analysis of clinical data showed no increased risk of cardiovascular events associated with wxe
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced results from a meta-analysis of cardiovascular (CV) events that showed no increased risk of CV events associated wi...- Amgen Inc new study shows Nplate(R) significantly reduces splenectomy rate and treatment failure i
- New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastu
- New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastu
Paladin Labs Announces GELICIOUS!(TM) and GELMEG3(TM) Launch
Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, today announced the launch of GELICIOUS!TM and GELMEG3TM, the first and only Omega 3 supplements in a tasty ...IDM Pharma reports second quater financial results
IDM Pharma, Inc.reported financial results for the quarter ended June 30, 2008. Financial information presented represents the consolidated results of IDM Pharma, Inc. and its subs...New analysis creates tool to quickly analyze where drugs go in the body
A team led by R. Graham Cooks, Purdue's Henry Bohn Hass Distinguished Professor of Chemistry, has developed a new analysis tool that can provide a map of the distribution of a drug...Publication
Global Pharma Management is a leading international magazine, published in India. The magazine is published two times in a year with a circulation figure of 75,015 (print + online, publisher's survey).
Advertising Products
B. Braun is one of the world's leading companies in international health-care.
The principal activities within customer projects are product variation and combination, pharmaceutical contract manufacturing and common development.
The principal activities within customer projects are product variation and combination, pharmaceutical contract manufacturing and common development.
 |
Pharmaceutical Supply Chain Efficiency
Press Releases
- Boehringer Ingelheim`s successful products show growth. Excellent progress in Research & Development
- Existing Collaboration Between Lilly and Covance
- Hollis-Eden Pharmaceuticals Commences Phase I/II Clinical Trial with TRIOLEX(TM) (HE3286)
- TracleerŪ (bosentan) receives EU approval for treatment of patients with mildly symptomatic Pulmonar
- Merck's First in Class Integrase Inhibitor, Reduced HIV Viral Load and Increased CD4 Cell Counts
White Papers
